The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 10, 2015

Filed:

Jun. 10, 2010
Applicants:

Motokazu Tsujikawa, Osaka, JP;

Yusuke Nakamura, Tokyo, JP;

Takuya Tsunoda, Kanagawa, JP;

Inventors:

Motokazu Tsujikawa, Osaka, JP;

Yusuke Nakamura, Tokyo, JP;

Takuya Tsunoda, Kanagawa, JP;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); A61P 35/00 (2006.01); C07K 14/515 (2006.01); A61P 9/10 (2006.01); A61P 27/02 (2006.01); A61K 38/08 (2006.01); B60N 2/225 (2006.01); C07K 14/00 (2006.01); C07K 14/71 (2006.01);
U.S. Cl.
CPC ...
B60N 2/2252 (2013.01); C07K 14/00 (2013.01); C07K 14/71 (2013.01); A61K 38/00 (2013.01);
Abstract

The present invention provides novel pharmaceutical agents and methods for treating or preventing diseases caused by neovascularization in human choroid (neovascular maculopathy). The present invention provides pharmaceutical compositions and vaccines for treating and/or preventing diseases caused by neovascularization in human choroid (neovascular maculopathy), comprising at least one type each of a peptide comprising an amino acid sequence derived from a VEGFR-1 protein and having an activity of inducing cytotoxic T cells, and a peptide comprising an amino acid sequence derived from a VEGFR-2 protein and having an activity of inducing cytotoxic T cells.


Find Patent Forward Citations

Loading…